文献速递前列腺增生与排尿功能障碍泌尿系感染男科与性医学

预测下尿路症状男性前列腺炎症的临床列线图的开发与验证

Development and validation of a clinical nomogram to predict prostatic inflammation in men with lower urinary tract symptoms.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2024-07-06

PINS研究为一项非干预性、横断面、前瞻性研究,在塞浦路斯、希腊、意大利、葡萄牙和西班牙的六个二级/三级中心纳入423例计划接受前列腺手术或经直肠超声引导前列腺穿刺活检的BPH/LUTS男性(≥40岁)。研究开发并验证了预测前列腺炎症(按Irani评分)的列线图,其一致性指数为0.71,内部效度良好。

要点

  • 列线图预测前列腺炎症的一致性指数为0.71,内部效度良好。
  • 前列腺体积超声>50 mL、尿路感染治疗史、糖尿病和IPSS储尿期评分是Irani分类的显著预测因素。
  • 尿试纸白细胞、糖尿病、PVUS>50 mL、UTI史和较高IPSS储尿期评分与Irani评分3-6分相比0-2分的比值比显著相关。

核心结论

  • 基于PINS研究开发的列线图具有良好的预测能力,并识别出多种前列腺炎症的预测特征。
  • 使用该列线图可能有助于通过识别适合靶向前列腺炎症治疗的患者,实现LUTS的个体化治疗。

研究设计与样本

  • 非干预性、横断面、前瞻性研究,在塞浦路斯、希腊、意大利、葡萄牙和西班牙的六个二级/三级中心开展。
  • 纳入423例≥40岁、患有BPH/LUTS并计划接受前列腺手术或经直肠超声引导前列腺穿刺活检的男性,平均年龄68.9岁。
  • 选择15项人口学和临床特征作为前列腺炎症的可能预测因素,通过手术/穿刺标本的Irani评分判定炎症存在。
  • 采用多元逻辑回归评估各特征对前列腺标本显示炎症(Irani评分分为0-2分[无/轻微炎症]或3-6分[中度/重度炎症]两类)可能性的影响,并开发列线图评估其区分能力和效度。

主要发现

  • 前列腺体积超声(PVUS)>50 mL、尿路感染(UTI)治疗史、糖尿病和IPSS储尿期评分是Irani分类的统计学显著预测因素。
  • 逻辑回归显示,尿试纸检测白细胞、糖尿病、PVUS>50 mL、UTI史和较高IPSS储尿期评分对Irani评分3-6分相比0-2分的比值比具有统计学显著影响。
  • 列线图的一致性指数为0.71,内部效度良好。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prostatic inflammation is an important etiological component of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). The Prostatic Inflammation Nomogram Study (PINS) aimed to develop and validate a nomogram for predicting the presence of prostatic inflammation in men with LUTS. METHODS: This non-interventional, cross-sectional, prospective study was conducted in six secondary/tertiary centers across Cyprus, Greece, Italy, Portugal, and Spain. Men (≥40 years) with BPH/LUTS scheduled to undergo prostatic surgery or transrectal ultrasound-guided (TRUS) prostate biopsy were included. Fifteen demographic and clinical participant characteristics were selected as possible predictors of prostatic inflammation. The presence of inflammation (according to Irani score) in the prostatic tissue samples obtained from surgery/TRUS biopsy was determined. The effect of each characteristic on the likelihood a prostate specimen demonstrated inflammation (classified by Irani score into two categories, 0-2 [no/minimal inflammation] or 3-6 [moderate/severe inflammation]) was assessed using multiple logistic regression. A nomogram was developed and its discriminatory ability and validity were assessed. RESULTS: In total, 423 patients (mean age 68.9 years) were recruited. Prostate volume ultrasound (PVUS) > 50 mL, history of urinary tract infection (UTI) treatment, presence of diabetes, and International Prostate Symptom Score (IPPS) Storage score were statistically significant predictors of Irani classification. Logistic regression demonstrated a statistically significant effect for leucocytes detected via urine dipstick, presence of diabetes, PVUS > 50 mL, history of UTIs, and higher IPSS Storage score for the odds of an inflammatory score category of 3-6 versus 0-2. The nomogram had a concordance index of 0.71, and good internal validity. CONCLUSIONS: The nomogram developed from PINS had good predictive ability and identified various characteristics to be predictors of prostatic inflammation. Use of the nomogram may aid in individualizing treatment for LUTS, by identifying individuals who are candidates for therapies targeting prostatic inflammation.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Gravas S, De Nunzio C, Campos Pinheiro L, et al. Development and validation of a clinical nomogram to predict prostatic inflammation in men with lower urinary tract symptoms. Prostate Cancer Prostatic Dis. 2024. PMID: 38971935. doi:10.1038/s41391-024-00857-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。